Literature DB >> 27516472

Clinical outcomes using minocycline for Stenotrophomonas maltophilia infections.

Shauna Jacobson1, Luis Junco Noa2, Mark R Wallace2, Mary Catherine Bowman2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27516472     DOI： 10.1093/jac/dkw327

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

1.  Antimicrobial Susceptibility of Acinetobacter calcoaceticus-Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997-2016).

Authors:  Ana C Gales; Harald Seifert; Deniz Gur; Mariana Castanheira; Ronald N Jones; Helio S Sader
Journal:  Open Forum Infect Dis       Date:  2019-03-15       Impact factor: 3.835

2.  Stenotrophomonas Bacteremia Antibiotic Susceptibility and Prognostic Determinants: Mayo Clinic 10-Year Experience.

Authors:  Ahmed M Hamdi; Madiha Fida; Omar M Abu Saleh; Elena Beam
Journal:  Open Forum Infect Dis       Date:  2020-01-19       Impact factor: 3.835

Review 3.  Overcoming Stenotrophomonas maltophilia Resistance for a More Rational Therapeutic Approach.

Authors:  Ravina Kullar; Eric Wenzler; Jose Alexander; Ellie J C Goldstein
Journal:  Open Forum Infect Dis       Date:  2022-03-21       Impact factor: 3.835
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.